PAVmed Inc expected to post a loss of 19 cents a share - Earnings Preview

PAVmed

12/08/2023 02:31

* PAVmed Inc  PAVM.OQ   PAVM.O  is expected to show a rise
in
quarterly revenue when it reports  results on August 14. 
    * The New York City-based  company is expected to report
revenue
of $525 thousand, according to the mean estimate from 4
analysts, based on Refinitiv data.  
    * ​Refinitiv's mean analyst estimate for PAVmed Inc is for a
loss
of 19 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for PAVmed Inc
is
$1.5​, above​ its last closing price of $0.31. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.21       -0.21      -0.19     Beat    8.1
 Dec. 31 2023  -0.26       -0.25      -0.23     Beat    9.2
 Sep. 30 2022  -0.27       -0.26      -0.29     Missed  -9.4​
 Jun. 30 2022  -0.23       -0.23      -0.29     Missed  -26.1
 ​​Mar.        -0.19       -0.19      -0.20     Missed  -2.6
 31 2022                                                
 Dec. 31 2021  -0.14       -0.15      -0.20     Missed  -33.3​
 Sep. 30 2021  -0.14       -0.13      -0.15     Missed  -15.4
 Jun. 30 2021  -0.10       -0.10      -0.14     Missed  -43.6
 This summary was machine generated August 12 at 01:31 GMT.  All
figures in US dollars  unless otherwise stated